重症患者胰岛素治疗与血糖管理:法国69个重症监护病房的1日横断面观察研究
该研究于2021年11月23日在法国69个ICU开展1日多中心观察,纳入因急性器官衰竭、严重感染或术后监护住院的成人患者,以4小时为时段记录数据。893例患者共采集4823个血糖值,各ICU间分布差异显著(P<0.0001);402例(45.0%)出现1135次高血糖(>1.8 g/L),26例(2.9%)出现35次低血糖(≤0.7 g/L),1次严重低血糖(≤0.4 g/L)。408例(45.7%)接受胰岛素治疗,其中静脉胰岛素255例(62.5%)、皮下胰岛素126例(30.9%)、两者兼有27例(6.6%);按方案静脉胰岛素治疗的患者中767/1681(45.6%)血糖高于目标范围。作者结论认为法国ICU血糖管理实践差异大,短效或长效皮下胰岛素使用并不少见且与更频繁的高血糖相关,所用方案化胰岛素算法未能预防高血糖事件。
要点
- 法国69个ICU中仅2个宣称无胰岛素方案,但各ICU血糖目标范围多达35种不同区间。
- 893例患者中402例(45.0%)出现高血糖(>1.8 g/L),共1135次;26例(2.9%)出现低血糖(≤0.7 g/L),共35次;严重低血糖(≤0.4 g/L)仅1次。
- 408例(45.7%)接受胰岛素:静脉255例(62.5%)、皮下126例(30.9%)、两者兼有27例(6.6%)。
- 按方案静脉胰岛素治疗者中767/1681(45.6%)血糖高于目标范围。
- 接受胰岛素者中,短效皮下胰岛素(发生率比3.45,95%CI 2.97-4.00,P<0.0001)和长效皮下胰岛素(发生率比3.58,95%CI 2.84-4.52,P<0.0001)与更多高血糖计数相关。
适用人群与场景
- 法国69个ICU中因急性器官衰竭、严重感染或术后监护住院的成人患者,研究当日纳入893例。
- 数据记录时间为2021年11月23日午夜至23:59,按4小时时段记录。
诊断标准与关键阈值
- 高血糖定义为>1.8 g/L,低血糖定义为≤0.7 g/L,严重低血糖定义为≤0.4 g/L。
- 各ICU记录的血糖目标范围共35种不同区间。
- 2个ICU宣称无胰岛素方案。
研究设计与关键结果
- 研究类型:多中心1日横断面观察研究,纳入法国69个ICU的893例成人患者。
- 主要结果:各ICU血糖值分布差异显著(P<0.0001);402例(45.0%)出现1135次高血糖(>1.8 g/L),26例(2.9%)出现35次低血糖(≤0.7 g/L),1次严重低血糖(≤0.4 g/L)。
- 胰岛素使用:408例(45.7%)接受胰岛素,其中静脉255例(62.5%)、皮下126例(30.9%)、两者兼有27例(6.6%)。
- 按方案静脉胰岛素治疗者中767/1681(45.6%)血糖高于目标范围。
- 多变量负二项回归(校正接受皮下胰岛素的倾向性)显示:短效皮下胰岛素与更高高血糖计数相关,发生率比3.45(95%CI 2.97-4.00,P<0.0001);长效皮下胰岛素发生率比3.58(95%CI 2.84-4.52,P<0.0001)。
证据类型、等级与局限
- 证据类型:多中心1日横断面观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为法国ICU血糖管理实践差异大,短效或长效皮下胰岛素使用并不少见且与更频繁的高血糖相关,所用方案化胰岛素算法未能预防高血糖事件。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hyperglycaemia is common in critically ill patients, but blood glucose and insulin management may differ widely among intensive care units (ICUs). We aimed to describe insulin use practices and the resulting glycaemic control in French ICUs. We conducted a multicentre 1-day observational study on November 23, 2021, in 69 French ICUs. Adult patients hospitalized for an acute organ failure, severe infection or post-operative care were included. Data were recorded from midnight to 11:59 p.m. the day of the study by 4-h periods.
RESULTS: Two ICUs declared to have no insulin protocol. There was a wide disparity in blood glucose targets between ICUs with 35 different target ranges recorded. In 893 included patients we collected 4823 blood glucose values whose distribution varied significantly across ICUs (P < 0.0001). We observed 1135 hyperglycaemias (> 1.8 g/L) in 402 (45.0%) patients, 35 hypoglycaemias (≤ 0.7 g/L) in 26 (2.9%) patients, and one instance of severe hypoglycaemia (≤ 0.4 g/L). Four hundred eight (45.7%) patients received either IV insulin (255 [62.5%]), subcutaneous (SC) insulin (126 [30.9%]), or both (27 [6.6%]). Among patients under protocolized intravenous (IV) insulin, 767/1681 (45.6%) of glycaemias were above the target range. Among patients receiving insulin, short- and long-acting SC insulin use were associated with higher counts of hyperglycaemias as assessed by multivariable negative binomial regression adjusted for the propensity to receive SC insulin: incidence rate ratio of 3.45 (95% confidence interval [CI] 2.97-4.00) (P < 0.0001) and 3.58 (95% CI 2.84-4.52) (P < 0.0001), respectively.
CONCLUSIONS: Practices regarding blood glucose management varied widely among French ICUs. Administration of short or long-acting SC insulin was not unusual and associated with more frequent hyperglycaemia. The protocolized insulin algorithms used failed to prevent hyperglycaemic events.
参考来源
- Desgrouas M, Demiselle J, Stiel L, et al. Insulin therapy and blood glucose management in critically ill patients: a 1-day cross-sectional observational study in 69 French intensive care units. Ann Intensive Care. 2023. PMID: 37330419. doi:10.1186/s13613-023-01142-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。